Vaxart, Inc.
VXRTOTCCIK 72444HealthcareFiscal year ends Dec 31
Reports and events: 451 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2025-05-1212:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-015960 |
| 2025-05-0512:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-014405 |
| 2025-04-2812:00 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events | 0001437749-25-013232 |
| 2025-04-1020:22 ET | DEF 14A | Proxy statementPeriod 2025-05-21 | 0001437749-25-011669 |
| 2025-03-2120:50 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001437749-25-008765 |
| 2025-03-2123:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-008617 |
| 2025-03-2020:11 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001437749-25-008572 |
| 2025-03-1112:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-006907 |
| 2025-02-2413:00 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events | 0001437749-25-004824 |
| 2025-02-1021:55 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001437749-25-003319 |
| 2025-01-2813:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-001949 |
| 2025-01-2114:41 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-001459 |
| 2024-12-3121:07 ET | 8-K | 3.01 Delisting notice | 0001437749-24-038599 |
| 2024-12-2714:21 ET | 8-K | 1.01 Entry into a material agreement | 0001437749-24-038436 |
| 2024-12-0522:52 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-036730 |
| 2024-11-1321:23 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001437749-24-034927 |
| 2024-11-1321:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-034897 |
| 2024-10-0820:05 ET | 8-K | 1.02 Termination of a material agreement | 0001437749-24-030878 |
| 2024-09-3021:20 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-030276 |
| 2024-08-0820:16 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001437749-24-025556 |
| 2024-08-0820:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-025539 |
| 2024-07-0520:16 ET | 8-K | 3.01 Delisting notice | 0001437749-24-022250 |
| 2024-06-2020:06 ET | 8-K/A | 5.07 Shareholder vote results | 0001437749-24-020779 |
| 2024-06-1821:52 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-020543 |
| 2024-06-1410:03 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-020250 |
| 2024-06-1321:26 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-020215 |
| 2024-06-1320:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-24-020194 |
| 2024-05-1320:11 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001437749-24-016236 |
| 2024-05-1320:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-016223 |
| 2024-04-3020:22 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-013983 |
| 2024-04-2920:37 ET | DEF 14A | Proxy statementPeriod 2024-06-11 | 0001437749-24-013723 |
| 2024-03-1420:46 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001437749-24-007865 |
| 2024-03-1420:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-007847 |
| 2024-03-0614:23 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-006743 |
| 2024-02-2921:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-24-006109 |
| 2024-02-1521:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-004353 |
| 2024-02-0221:49 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-24-002971 |
| 2024-01-1922:14 ET | 8-K | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-001757 |
| 2024-01-1622:18 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-001419 |
| 2024-01-1614:19 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-001326 |
| 2023-11-0220:16 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001437749-23-030009 |
| 2023-11-0220:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-23-030004 |
| 2023-10-2321:09 ET | 8-K/A | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-23-028779 |
| 2023-10-2321:01 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001437749-23-028774 |
| 2023-09-0620:43 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-23-025314 |
| 2023-08-0320:30 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001437749-23-021966 |
| 2023-08-0320:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-23-021953 |
| 2023-07-2620:20 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001437749-23-020716 |
| 2023-07-1020:12 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-23-019649 |
| 2023-06-2820:22 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-23-018762 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:53 ET. Listed shows no prices and gives no investment advice.